{'fraction_non_alphanumeric': 0.037267080745341616, 'fraction_numerical': 0.043478260869565216, 'mean_word_length': 5.262135922330097, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Transmyocardial laser revascularization 12 years later.

We report the long-term follow-up of 34 patients who underwent transmyocardial laser revascularization (TMLR) from 1995 to 1999. At 12 years the actuarial survival is 24%±8%, actuarial freedom from cardiac deaths is 36%±10% and actuarial freedom from major adverse cardiac events 13%±8%. Mean angina class of nine current survivors is 2.7±0.6. Based on these results, the use of TMLR as an isolated procedure remains questionable. TMLR could probably achieve better results when employed in combination with myocardial revascularization or as a vehicle of intramyocardial growth factors.